Maintenance Therapy of Psychosis Spectrum Disorders in a Real-World Setting: Antipsychotics Prescription Patterns and Long-Term Benzodiazepine Use
Lorazepam
DOI:
10.3389/fpsyt.2022.796719
Publication Date:
2022-04-07T06:09:57Z
AUTHORS (12)
ABSTRACT
Maintenance therapy of patients with primary psychosis spectrum disorders (PSD) in the Western Balkans has received limited interest so far. The present study aimed to investigate long-term prescription patterns among outpatients PSD.Information about antipsychotics (AP), benzodiazepines (BZD) and other psychotropic medication over a 6-month period was collected from (n = 134; ICD-10 diagnosis F20-29) recruited by larger multi-site study, find mean daily number drugs, AP (including dose, route administration, monotherapy vs. polypharmacy) BZD utilization (long-term add-on therapy). Additionally, sex-differences variables were explored.Clinically stable (age 41.7 ± 11.0; male 62.7%; duration untreated illness 12.7 8.7 years; lifetime hospitalizations 2.6 0.7) prescribed 2.8 1.1 medications daily. dose 14.2 7.8 mg olanzapine equivalents. Long-acting injectable 25.2% patients. Long-term found 52.7% most them second generation (65.2%). polypharmacy (42.7%) more common males (p 0.015). frequent co-prescription first plus clozapine. highest rate for (in 42.7% cases, average 6-months 2.7 lorazepam equivalents) anticholinergics (33.6%).Existing appropriately designed interventions aiming safely switch inappropriate therapeutic regimens, i.e. very high prevalence non-rational co-prescription, should be implemented region Balkans.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....